Renhe Pharmacy Co Ltd (000650) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Renhe Pharmacy Co Ltd (000650) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥188.23 Million ≈ $27.54 Million USD) by net assets (CN¥7.04 Billion ≈ $1.03 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Renhe Pharmacy Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Renhe Pharmacy Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 000650 total liabilities for a breakdown of total debt and financial obligations.
Renhe Pharmacy Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Renhe Pharmacy Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenyang Toly Bread Co Ltd
SHG:603866
|
0.043x |
|
Johnson Health Tech Co Ltd
TW:1736
|
-0.003x |
|
CHINA RISUN GROUP HD-10
F:45Y
|
N/A |
|
Trinity Capital Inc
NASDAQ:TRIN
|
0.027x |
|
Shenzhen Farben Information Technology Co.Ltd.
SHE:300925
|
N/A |
|
Vizsla Silver Corp.
TO:VZLA
|
-0.003x |
|
Shen Zhen Bauing Construction Holding Group Co Ltd
SHE:002047
|
2.259x |
|
Tetra Technologies Inc
NYSE:TTI
|
0.112x |
Annual Cash Flow Conversion Efficiency for Renhe Pharmacy Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Renhe Pharmacy Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Renhe Pharmacy Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.81 Billion ≈ $995.93 Million |
CN¥557.26 Million ≈ $81.54 Million |
0.082x | +9.09% |
| 2023-12-31 | CN¥6.65 Billion ≈ $973.76 Million |
CN¥499.47 Million ≈ $73.09 Million |
0.075x | -62.05% |
| 2022-12-31 | CN¥6.42 Billion ≈ $939.71 Million |
CN¥1.27 Billion ≈ $185.84 Million |
0.198x | +50.71% |
| 2021-12-31 | CN¥5.93 Billion ≈ $867.29 Million |
CN¥777.72 Million ≈ $113.80 Million |
0.131x | -15.49% |
| 2020-12-31 | CN¥5.61 Billion ≈ $820.99 Million |
CN¥871.13 Million ≈ $127.47 Million |
0.155x | -2.63% |
| 2019-12-31 | CN¥4.35 Billion ≈ $636.83 Million |
CN¥693.97 Million ≈ $101.55 Million |
0.159x | +9.63% |
| 2018-12-31 | CN¥3.91 Billion ≈ $572.89 Million |
CN¥569.45 Million ≈ $83.33 Million |
0.145x | +1.45% |
| 2017-12-31 | CN¥3.47 Billion ≈ $508.13 Million |
CN¥497.86 Million ≈ $72.85 Million |
0.143x | -12.00% |
| 2016-12-31 | CN¥3.20 Billion ≈ $468.92 Million |
CN¥522.08 Million ≈ $76.40 Million |
0.163x | -2.54% |
| 2015-12-31 | CN¥2.60 Billion ≈ $380.59 Million |
CN¥434.77 Million ≈ $63.62 Million |
0.167x | -1.06% |
| 2014-12-31 | CN¥2.16 Billion ≈ $316.38 Million |
CN¥365.27 Million ≈ $53.45 Million |
0.169x | +53.53% |
| 2013-12-31 | CN¥1.94 Billion ≈ $283.72 Million |
CN¥213.36 Million ≈ $31.22 Million |
0.110x | +2.41% |
| 2012-12-31 | CN¥1.71 Billion ≈ $250.53 Million |
CN¥183.97 Million ≈ $26.92 Million |
0.107x | -26.48% |
| 2011-12-31 | CN¥1.14 Billion ≈ $167.13 Million |
CN¥166.93 Million ≈ $24.43 Million |
0.146x | +2.48% |
| 2010-12-31 | CN¥912.05 Million ≈ $133.46 Million |
CN¥130.07 Million ≈ $19.03 Million |
0.143x | -39.05% |
| 2009-12-31 | CN¥857.16 Million ≈ $125.43 Million |
CN¥200.58 Million ≈ $29.35 Million |
0.234x | +15.08% |
| 2008-12-31 | CN¥305.60 Million ≈ $44.72 Million |
CN¥62.14 Million ≈ $9.09 Million |
0.203x | +35.25% |
| 2007-12-31 | CN¥235.44 Million ≈ $34.45 Million |
CN¥35.40 Million ≈ $5.18 Million |
0.150x | -87.56% |
| 2006-12-31 | CN¥194.71 Million ≈ $28.49 Million |
CN¥235.28 Million ≈ $34.43 Million |
1.208x | +421.39% |
| 2005-12-31 | CN¥46.88 Million ≈ $6.86 Million |
CN¥-17.63 Million ≈ $-2.58 Million |
-0.376x | -462.08% |
| 2004-12-31 | CN¥169.04 Million ≈ $24.74 Million |
CN¥17.55 Million ≈ $2.57 Million |
0.104x | +149.33% |
| 2003-12-31 | CN¥238.17 Million ≈ $34.85 Million |
CN¥-50.14 Million ≈ $-7.34 Million |
-0.211x | -354.75% |
| 2002-12-31 | CN¥338.74 Million ≈ $49.57 Million |
CN¥27.99 Million ≈ $4.10 Million |
0.083x | +702.09% |
| 2001-12-31 | CN¥331.58 Million ≈ $48.52 Million |
CN¥3.42 Million ≈ $499.90K |
0.010x | +109.60% |
| 2000-12-31 | CN¥345.32 Million ≈ $50.53 Million |
CN¥-37.08 Million ≈ $-5.43 Million |
-0.107x | -141.68% |
| 1999-12-31 | CN¥261.49 Million ≈ $38.26 Million |
CN¥67.37 Million ≈ $9.86 Million |
0.258x | +316.08% |
| 1998-12-31 | CN¥233.76 Million ≈ $34.21 Million |
CN¥14.48 Million ≈ $2.12 Million |
0.062x | -- |
About Renhe Pharmacy Co Ltd
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more